×

Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation

  • US 9,804,151 B2
  • Filed: 10/25/2013
  • Issued: 10/31/2017
  • Est. Priority Date: 03/07/2006
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a disease, disorder, or condition comprising:

  • (1) introducing hES cells, derivatives of hES cells, or combinations thereof in a cell culture medium consisting of minimal essential medium, a progestin, and a β

    -human chorionic gonadotrophin (β

    hCG) agonist, wherein the derivatives of hES cells are selected from the group consisting of hematopoietic stem cell progenitors, neuronal stem cell progenitors, mesenchymal stem cell progenitors, insulin producing stem cell progenitors, bilirubin producing stem cell progenitors, albumin producing stem cell progenitors, hepatocytic stem cell progenitors, cardiac stem cell progenitors, epithelial stem cell progenitors, and combinations thereof;

    (2) expanding the cells obtained in (1) at a temperature of about 34°

    C. to about 38°

    C. in an environment of about 3.5% to about 6% carbon dioxide for about 12 hours to about 48 hours; and

    (3) administering to a subject a therapeutically effective amount of the cells obtained in (2).

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×